Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
Government Accountability Office (GAO) Individual Patient Access to Investigational Drugs for Serious Diseases (Parallel Track Policy) (§ 561) Prescription Drug Advertising: Manufacturer to Consumer Switch of Prescription Drugs to Over-the-Counter Drugs Overview of Important Developments in Medicaid and Prescription Drug Reimbursement See U.S. Government Accountability Office (GAO)
General Motors Corporation v. Caldwell (1986)
generic drug labeling controversies
generic medications dispensing, substitutions Drug Price Competition and Patent Term Restoration Act (PTRA) of 1984 Generic Drug Enforcement Act (1992) marketed unapproved drugs pfizer V. shalala (1998) - Pfizer, Inc. V. Shalala winn dixie of montgomery, inc. V. colburn (1998) - Winn Dixie of Montgomery, Inc. V. Colburn antitrust litigation Drug Efficacy Study Implementation (DESI) Drug Price Competition and Patent Term Restoration Act (PTRA) of 1984 investigational drugs, access to natural monopoly section 505(b)(2) applications “paper” new drug applications
See Good Manufacturing Practices (GMP) Cosmetics Kefauver-Harris Amendment of 1962 See Good Manufacturing Practices (GMP) Explanation of Adulteration Medical Device Amendments of 1976
Good Manufacturing Practices (GMP) adulteration regulations Law Made by Administrative Agencies establishment of
Frost (1989) Purpose of a Controlled Substance Prescription Gordon v. Frost
grand jury
See generally recognized as safe and effective (GRASE) New Drug Approval See generally recognized as safe and effective (GRASE) Defining "New Drug" Over-the-Counter Drug Review
Griffiths v. Medical Board of California (2002)
guidance documents, overview
generally recognized as safe and effective (GRASE)
Generic Drug Enforcement Act (1992)
Gonzales v. Raich (2005)
government regulation, medicinal drugs
Griffin v. Phar-Mor, Inc. (1992)
Group Life and Health Insurance Co. v. Royal Drug Co. (1979)